Company Overview of Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc., a biotechnology company, develops vaccines for the prevention of common seasonal influenza and emergent pandemic flu. It focuses on developing live attenuated influenza vaccines by altering the gene for nonstructural protein 1 (NS1), a key virulence factor of influenza, and other negative-strand RNA viruses. The company was founded in 2006 and is based in New York, New York.
3185-A Rampart Road
Research Innovation Center
Fort Collins, CO 80523-0922
Founded in 2006
970 492 4365
Key Executives for Vivaldi Biosciences, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Vivaldi Biosciences, Inc., please visit www.vivaldibiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.